Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Share-based Compensation (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Share-based Compensation data on record, last reported at $204000.0 in Q1 2013.

  • For Q1 2013, Share-based Compensation fell 55.65% year-over-year to $204000.0; the TTM value through Mar 2013 reached $1.4 million, down 48.84%, while the annual FY2025 figure was $224000.0, 56.59% down from the prior year.
  • Share-based Compensation reached $204000.0 in Q1 2013 per SNOA's latest filing, down from $456000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.0 million in Q4 2011 and bottomed at $204000.0 in Q1 2013.
  • Average Share-based Compensation over 4 years is $549750.0, with a median of $487500.0 recorded in 2011.
  • Peak YoY movement for Share-based Compensation: skyrocketed 187.5% in 2011, then plummeted 55.65% in 2013.
  • A 4-year view of Share-based Compensation shows it stood at $352000.0 in 2010, then surged by 187.5% to $1.0 million in 2011, then plummeted by 54.94% to $456000.0 in 2012, then tumbled by 55.26% to $204000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $204000.0 in Q1 2013, $456000.0 in Q4 2012, and $372000.0 in Q3 2012.